FOUNDERS FINANCIAL SECURITIES LLC
Broker-DealerPosition in NVS — Novartis AG
CIK 1342396
TOWSON, MD
Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$411,860
+$34,097 QoQ
Shares Held
2,628
-4.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#977
of 1,603 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FOUNDERS FINANCIAL SECURITIES LLC holds $21,446,689 across 11 Drug Manufacturers - General names. NVS ranks #10 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
23,408 | $5,944,929 | |
| 2 | AMGN |
Amgen Inc
|
8,037 | $2,910,358 | |
| 3 | MRK |
Merck & Co., Inc.
|
19,290 | $2,478,765 | |
| 4 | ABBV |
AbbVie Inc.
|
9,802 | $2,466,575 | |
| 5 | AZN |
Astrazeneca PLC
|
12,714 | $2,410,828 | |
| 6 | LLY |
ELI LILLY & Co
|
1,169 | $1,402,133 | |
| 7 | GSK |
GSK plc
|
21,673 | $1,136,098 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,321 | $1,051,275 |
All Filings in NVS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $411,860 | 2,628 | Shares | Sole | 2026-07-31 | |
| 2025-12-31 | $377,763 | 2,740 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $337,014 | 2,628 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $342,700 | 2,832 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $318,498 | 2,857 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $269,548 | 2,770 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $324,356 | 2,820 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $301,494 | 2,832 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $264,846 | 2,738 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $244,347 | 2,420 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $257,603 | 2,529 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $255,201 | 2,529 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $205,068 | 2,229 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $202,214 | 2,229 | Shares | Sole | 2023-02-08 | |
| 2022-06-30 | $210,564 | 2,491 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $218,585 | 2,491 | Shares | Sole | 2022-05-13 | |
| 2021-06-30 | $202,279 | 2,217 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||